News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
770,268 Results
Type
Article (52613)
Company Profile (291)
Press Release (717343)
Multimedia
Podcasts (147)
Webinars (23)
Section
Business (213144)
Career Advice (2978)
Deals (36748)
Drug Delivery (151)
Drug Development (84596)
Employer Resources (184)
FDA (17109)
Job Trends (15801)
News (361699)
Policy (34951)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2876)
Accelerated approval (47)
Adcomms (33)
Allergies (176)
Alliances (51610)
ALS (222)
Alzheimer's disease (1870)
Antibody-drug conjugate (ADC) (474)
Approvals (17444)
Artificial intelligence (703)
Autoimmune disease (300)
Automation (58)
Bankruptcy (372)
Best Places to Work (12097)
BIOSECURE Act (22)
Biosimilars (229)
Biotechnology (182)
Bladder cancer (198)
Brain cancer (75)
Breast cancer (765)
Cancer (5979)
Cardiovascular disease (502)
Career advice (2541)
Career pathing (49)
CAR-T (348)
CDC (68)
Celiac Disease (3)
Cell therapy (943)
Cervical cancer (48)
Clinical research (73046)
Collaboration (2138)
Company closure (7)
Compensation (1436)
Complete response letters (90)
COVID-19 (2921)
CRISPR (116)
C-suite (1156)
Cystic fibrosis (160)
Data (8024)
Decentralized trials (3)
Denatured (35)
Depression (175)
Dermatology (89)
Diabetes (608)
Diagnostics (7186)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (333)
Drug pricing (224)
Drug shortages (36)
Duchenne muscular dystrophy (299)
Earnings (95662)
Editorial (76)
Employer branding (22)
Employer resources (163)
Events (125439)
Executive appointments (1110)
FDA (20901)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1771)
Gene editing (251)
Generative AI (61)
Gene therapy (784)
GLP-1 (1156)
Government (5145)
Grass and pollen (6)
Guidances (408)
Healthcare (20058)
HIV (85)
Huntington's disease (58)
IgA nephropathy (100)
Immunology and inflammation (312)
Immuno-oncology (101)
Indications (195)
Infectious disease (3276)
Inflammatory bowel disease (225)
Inflation Reduction Act (14)
Influenza (139)
Intellectual property (296)
Interviews (534)
IPO (17108)
IRA (55)
Job creations (4015)
Job search strategy (2073)
JPM (67)
Kidney cancer (19)
Labor market (101)
Layoffs (621)
Leadership (49)
Legal (8613)
Liver cancer (104)
Longevity (32)
Lung cancer (783)
Lymphoma (436)
Machine learning (62)
Management (64)
Manufacturing (1097)
MASH (196)
Medical device (14456)
Medtech (14584)
Mergers & acquisitions (20900)
Metabolic disorders (1600)
mRNA (231)
Multiple sclerosis (192)
NASH (22)
Neurodegenerative disease (442)
Neuropsychiatric disorders (116)
Neuroscience (3449)
Neurotech (1)
NextGen: Class of 2026 (7025)
Non-profit (4888)
Now hiring (78)
Obesity (760)
Opinion (355)
Ovarian cancer (227)
Pain (261)
Pancreatic cancer (312)
Parkinson's disease (373)
Partnered (33)
Patents (609)
Patient recruitment (684)
Peanut (65)
People (61454)
Pharmaceutical (64)
Pharmacy benefit managers (33)
Phase 1 (22717)
Phase 2 (32107)
Phase 3 (24000)
Pipeline (8869)
Policy (354)
Postmarket research (2761)
Preclinical (9834)
Press Release (67)
Prostate cancer (309)
Psychedelics (63)
Radiopharmaceuticals (332)
Rare diseases (1155)
Real estate (6345)
Recruiting (74)
Regulatory (26785)
Reports (57)
Research institute (2612)
Resumes & cover letters (487)
Rett syndrome (40)
RNA editing (25)
RSV (91)
Schizophrenia (184)
Series A (300)
Series B (221)
Service/supplier (12)
Sickle cell disease (118)
Special edition (30)
Spinal muscular atrophy (176)
Sponsored (49)
Startups (3844)
State (2)
Stomach cancer (19)
Supply chain (131)
Tariffs (96)
The Weekly (109)
Vaccines (1185)
Venture capital (113)
Weight loss (511)
Women's health (131)
Worklife (24)
Date
Today (156)
Last 7 days (922)
Last 30 days (3623)
Last 365 days (31178)
2026 (13009)
2025 (31176)
2024 (36207)
2023 (41186)
2022 (52491)
2021 (57208)
2020 (55906)
2019 (48884)
2018 (37098)
2017 (33939)
2016 (33801)
2015 (39670)
2014 (33358)
2013 (28530)
2012 (30756)
2011 (31348)
2010 (29373)
Location
Africa (910)
Alabama (98)
Alaska (7)
Arizona (368)
Arkansas (14)
Asia (42861)
Australia (7153)
California (13513)
Canada (3812)
China (1390)
Colorado (579)
Connecticut (595)
Delaware (417)
Europe (94818)
Florida (2022)
Georgia (434)
Hawaii (3)
Idaho (65)
Illinois (1083)
India (92)
Indiana (622)
Iowa (23)
Japan (549)
Kansas (135)
Kentucky (53)
Louisiana (41)
Maine (77)
Maryland (1637)
Massachusetts (9702)
Michigan (370)
Minnesota (727)
Mississippi (6)
Missouri (155)
Montana (36)
Nebraska (29)
Nevada (147)
New Hampshire (84)
New Jersey (3567)
New Mexico (31)
New York (3536)
North Carolina (1786)
North Dakota (9)
Northern California (6757)
Ohio (406)
Oklahoma (25)
Oregon (43)
Pennsylvania (2708)
Puerto Rico (30)
Rhode Island (50)
South America (1308)
South Carolina (87)
South Dakota (2)
Southern California (5335)
Tennessee (214)
Texas (2146)
United States (47889)
Utah (402)
Vermont (1)
Virginia (334)
Washington D.C. (82)
Washington State (1081)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
770,268 Results for "one lambda inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Resverlogix Announces One-Year Extension of Debenture
May 11, 2026
·
2 min read
Press Releases
FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
May 7, 2026
·
2 min read
Manufacturing
FDA pilots AI-informed one-day facility inspections
Implemented as part of a broader initiative to make more targeted and efficient use of inspection resources, the pilot program will use artificial intelligence to enable shorter, focused screenings to complement standard FDA inspections.
May 7, 2026
·
2 min read
·
Nick Paul Taylor
FDA
FDA’s One Trial Policy Not a Revolution but a Potentially Risky Evolution
Last week, the FDA made its one pivotal trial policy official, sparking myriad questions from industry leaders, including around specific evidence required for the single study and why it hasn’t been implemented across all therapeutic areas before now.
February 26, 2026
·
7 min read
·
Heather McKenzie
Press Releases
LambdaVision and Helogen Partner to Advance Space-Based Biomaterial Manufacturing
May 18, 2026
·
5 min read
Press Releases
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
April 27, 2026
·
6 min read
Press Releases
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
November 11, 2025
·
7 min read
Press Releases
Jaguar Health Announces a Special One-time Stock Dividend
February 18, 2026
·
6 min read
Press Releases
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 23, 2026
·
3 min read
Press Releases
Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference
November 21, 2025
·
1 min read
1 of 77,027
Next
